Aspen Aerogels, Inc.
NYSE:ASPN
24.88 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 238.718 | 180.364 | 121.622 | 100.273 | 139.375 | 104.361 | 111.631 | 117.738 | 122.518 | 102.399 | 86.094 | 63.453 | 45.95 | 43.209 | 28.616 | 121.622 |
| Cost of Revenue
| 181.797 | 175.388 | 111.685 | 85.679 | 113.091 | 91.692 | 92.96 | 94.427 | 97.87 | 85.319 | 75.363 | 71.421 | 48.576 | 37.518 | 32.25 | 111.685 |
| Gross Profit
| 56.921 | 4.976 | 9.937 | 14.594 | 26.284 | 12.669 | 18.671 | 23.311 | 24.648 | 17.08 | 10.731 | -7.968 | -2.626 | 5.691 | -3.634 | 9.937 |
| Gross Profit Ratio
| 0.238 | 0.028 | 0.082 | 0.146 | 0.189 | 0.121 | 0.167 | 0.198 | 0.201 | 0.167 | 0.125 | -0.126 | -0.057 | 0.132 | -0.127 | 0.082 |
| Reseach & Development Expenses
| 16.356 | 16.93 | 11.441 | 8.729 | 8.407 | 6.319 | 6.18 | 5.306 | 5.253 | 5.98 | 5.159 | 5.142 | 4.085 | 2.985 | 2.524 | 11.441 |
| General & Administrative Expenses
| 56.76 | 38.499 | 22.514 | 15.681 | 16.479 | 19.116 | 19.023 | 17.415 | 15.068 | 16.853 | 13.418 | 11.299 | 8.914 | 5.675 | 5.43 | 22.514 |
| Selling & Marketing Expenses
| 33.008 | 28.792 | 16.581 | 11.753 | 15.557 | 13.794 | 12.604 | 11.81 | 10.562 | 10.29 | 9.271 | 8.564 | 5.565 | 4.526 | 3.994 | 16.581 |
| SG&A
| 89.768 | 67.291 | 39.095 | 27.434 | 32.036 | 32.91 | 31.627 | 29.225 | 25.63 | 27.143 | 22.689 | 19.863 | 14.479 | 10.201 | 9.424 | 39.095 |
| Other Expenses
| 2.186 | 0 | 0 | 0 | 0 | 7.356 | -0.9 | -0.5 | 0 | 0 | -5.697 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 106.124 | 84.221 | 50.536 | 36.163 | 40.443 | 39.229 | 37.807 | 34.531 | 30.883 | 33.123 | 27.848 | 25.005 | 18.564 | 13.186 | 11.948 | 50.536 |
| Operating Income
| -49.203 | -79.245 | -40.599 | -21.569 | -14.159 | -33.916 | -19.136 | -11.22 | -6.235 | -16.043 | -19.972 | -32.973 | -20.567 | -7.495 | -15.582 | -40.599 |
| Operating Income Ratio
| -0.206 | -0.439 | -0.334 | -0.215 | -0.102 | -0.325 | -0.171 | -0.095 | -0.051 | -0.157 | -0.232 | -0.52 | -0.448 | -0.173 | -0.545 | -0.334 |
| Total Other Income Expenses Net
| 3.392 | -3.493 | 3.505 | -0.24 | -0.406 | -7.356 | -0.185 | -0.803 | -0.182 | -50.281 | -0.239 | -1.379 | -12.265 | 0 | 0 | 3.505 |
| Income Before Tax
| -45.811 | -82.738 | -37.094 | -21.809 | -14.565 | -34.44 | -19.321 | -12.023 | -6.417 | -66.324 | -47.611 | -56.142 | -32.832 | 0 | 0 | -37.094 |
| Income Before Tax Ratio
| -0.192 | -0.459 | -0.305 | -0.217 | -0.105 | -0.33 | -0.173 | -0.102 | -0.052 | -0.648 | -0.553 | -0.885 | -0.715 | 0 | 0 | -0.305 |
| Income Tax Expense
| 18.009 | 3.493 | -9.211 | -9.958 | -9.807 | -10.263 | -10.753 | -10.509 | -9.887 | -10.183 | 24.317 | 21.79 | -4.69 | 2.415 | 3.057 | 0 |
| Net Income
| -45.811 | -86.231 | -27.883 | -11.851 | -4.758 | -34.44 | -19.321 | -12.023 | -6.417 | -66.324 | -47.611 | -56.142 | -32.832 | -9.91 | -18.639 | -37.094 |
| Net Income Ratio
| -0.192 | -0.478 | -0.229 | -0.118 | -0.034 | -0.33 | -0.173 | -0.102 | -0.052 | -0.648 | -0.553 | -0.885 | -0.715 | -0.229 | -0.651 | -0.305 |
| EPS
| -0.66 | -2.19 | -0.92 | -0.45 | -0.2 | -1.45 | -0.83 | -0.52 | -0.28 | -5.37 | -2.07 | -3.64 | -2.13 | -0.64 | -1.21 | -0.001 |
| EPS Diluted
| -0.66 | -2.19 | -0.92 | -0.45 | -0.2 | -1.45 | -0.83 | -0.52 | -0.28 | -5.37 | -2.07 | -3.64 | -2.13 | -0.64 | -1.21 | -0.001 |
| EBITDA
| -31.026 | -77.628 | -40.599 | -21.569 | -14.159 | -26.56 | -19.136 | -11.876 | -6.235 | -16.043 | -12.994 | -23.289 | -17.736 | -2.862 | -9.952 | -40.599 |
| EBITDA Ratio
| -0.13 | -0.43 | -0.334 | -0.215 | -0.102 | -0.255 | -0.171 | -0.101 | -0.051 | -0.157 | -0.151 | -0.367 | -0.386 | -0.066 | -0.348 | -0.334 |